Dapagliflozin is a medication used primarily to manage type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which work by helping the kidneys remove excess glucose from the bloodstream through urine. This can lead to improved blood sugar control and may also aid in weight loss. In addition to its use in diabetes, Dapagliflozin has been studied for its potential benefits in treating heart failure and chronic kidney disease. By reducing the workload on the heart and improving kidney function, it may help enhance overall health in patients with these conditions.